Heron Therapeutics(DE:AXD2)
€0.33+0.08 (+34.15%)
DE:AXD2
Heron Therapeutics Revenue
€0.33
At close:+0.08 (+34.15%)
Heron Therapeutics (AXD2) Revenue
4 Followers
Heron Therapeutics Revenue
Heron Therapeutics had a revenue of 35.25M in the quarter ending Sep 30, 2026, with -6.41%. This bring the company's revenue in the last twelve months to 148.22M, Decreased 1.96%. In the fiscal year ending Dec 31, 2025, Heron Therapeutics had annual revenue of 154.90M with 7.36% growth.
- Revenue (ttm)
- 148.22M
- Revenue Growth
- -9.34%
- P/S Ratio
- 0.41
- Revenue/Employee
- EUR 1,210,188
- Employees
- 128
- Market Cap
- EUR 64.15M
Revenue Chart
Heron Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 154.90M | 10.62M | 7.36% |
| Dec 31, 2024 | 144.28M | 17.24M | 13.57% |
| Dec 31, 2023 | 127.04M | 19.37M | 17.99% |
| Dec 31, 2022 | 107.67M | 21.33M | 24.70% |
| Dec 31, 2021 | 86.35M | -2.29M | -2.59% |
| Dec 31, 2020 | 88.64M | -57.33M | -39.28% |
| Dec 31, 2019 | 145.97M | 68.49M | 88.41% |
| Dec 31, 2018 | 77.47M | 46.71M | 151.81% |
| Dec 31, 2017 | 30.77M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.